Exploring the 'N-terminal arm' & 'Convex surface' binding Interfaces of the T3SS Chaperone-Translocator Complexes from P. aeruginosa.
暂无分享,去创建一个
[1] Angray S. Kang,et al. Exploring the “N-Terminal Anchor” Binding Interface of the T3SS Chaperone–Translocator Complexes from P. aeruginosa , 2023, Biochemistry.
[2] P. Sansonetti,et al. Structural Insights of Shigella Translocator IpaB and Its Chaperone IpgC in Solution , 2021, Frontiers in Cellular and Infection Microbiology.
[3] Julia A Hotinger,et al. Molecular Targets and Strategies for Inhibition of the Bacterial Type III Secretion System (T3SS); Inhibitors Directly Binding to T3SS Components , 2021, Biomolecules.
[4] Michael T. Stumpp,et al. Beyond Antibodies: The DARPin® Drug Platform , 2020, BioDrugs.
[5] E. Faure,et al. Pseudomonas aeruginosa in Chronic Lung Infections: How to Adapt Within the Host? , 2018, Front. Immunol..
[6] S. Wagner,et al. Bacterial type III secretion systems: a complex device for the delivery of bacterial effector proteins into eukaryotic host cells , 2018, FEMS microbiology letters.
[7] P. Sansonetti,et al. Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors. , 2018, Trends in microbiology.
[8] M. Mingeot-Leclercq,et al. Targeting the Type Three Secretion System in Pseudomonas aeruginosa. , 2016, Trends in pharmacological sciences.
[9] M. Valls,et al. Modification of Bacterial Effector Proteins Inside Eukaryotic Host Cells , 2016, Front. Cell. Infect. Microbiol..
[10] John Chilton,et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update , 2016, Nucleic Acids Res..
[11] A. Economou,et al. Type III Secretion: Building and Operating a Remarkable Nanomachine. , 2016, Trends in biochemical sciences.
[12] Yunhan Hong,et al. Structure of AcrH-AopB Chaperone-Translocator Complex Reveals a Role for Membrane Hairpins in Type III Secretion System Translocon Assembly. , 2015, Structure.
[13] T. Heyduk,et al. Next Generation Sequencing-based analysis of RNA polymerase functions. , 2015, Methods.
[14] S. Chakrabarti,et al. Binding mode analysis of a major T3SS translocator protein PopB with its chaperone PcrH from Pseudomonas aeruginosa , 2014, Proteins.
[15] Wei Zhao,et al. A multifunctional bispecific antibody protects against Pseudomonas aeruginosa , 2014, Science Translational Medicine.
[16] Samuel Wagner,et al. Bacterial type III secretion systems: specialized nanomachines for protein delivery into target cells. , 2014, Annual review of microbiology.
[17] P. Sansonetti,et al. Type III secretion system , 2014, Current Biology.
[18] F. Accurso,et al. Anti‐PcrV antibody in cystic fibrosis: A novel approach targeting Pseudomonas aeruginosa airway infection , 2014, Pediatric pulmonology.
[19] J. Simorre,et al. Membrane and Chaperone Recognition by the Major Translocator Protein PopB of the Type III Secretion System of Pseudomonas aeruginosa* , 2013, The Journal of Biological Chemistry.
[20] B. Raymond,et al. Subversion of trafficking, apoptosis, and innate immunity by type III secretion system effectors. , 2013, Trends in microbiology.
[21] Dong Xu,et al. Toward optimal fragment generations for ab initio protein structure assembly , 2013, Proteins.
[22] S. Lory,et al. Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia. , 2012, American journal of respiratory and critical care medicine.
[23] A. Boyle,et al. LcrH, a Class II Chaperone from the Type Three Secretion System, Has a Highly Flexible Native Structure* , 2012, The Journal of Biological Chemistry.
[24] Yang Zhang,et al. Ab initio protein structure assembly using continuous structure fragments and optimized knowledge‐based force field , 2012, Proteins.
[25] H. Niemann,et al. Crystal structure of the Yersinia enterocolitica type III secretion chaperone SycD in complex with a peptide of the minor translocator YopD , 2012, BMC Structural Biology.
[26] B. Geisbrecht,et al. Binding affects the tertiary and quaternary structures of the Shigella translocator protein IpaB and its chaperone IpgC. , 2012, Biochemistry.
[27] E. Komives,et al. Visualization of the nanospring dynamics of the IκBα ankyrin repeat domain in real time , 2011, Proceedings of the National Academy of Sciences.
[28] M. Kolbe,et al. Combination of Two Separate Binding Domains Defines Stoichiometry between Type III Secretion System Chaperone IpgC and Translocator Protein IpaB , 2010, The Journal of Biological Chemistry.
[29] A. Dessen,et al. Structural Basis of Chaperone Recognition of Type III Secretion System Minor Translocator Proteins* , 2010, The Journal of Biological Chemistry.
[30] A. Hauser. The type III secretion system of Pseudomonas aeruginosa: infection by injection , 2009, Nature Reviews Microbiology.
[31] K. Leung,et al. Mapping of the chaperone AcrH binding regions of translocators AopB and AopD and characterization of oligomeric and metastable AcrH‐AopB‐AopD complexes in the type III secretion system of Aeromonas hydrophila , 2009, Protein science : a publication of the Protein Society.
[32] M. Kolbe,et al. IpaB–IpgC interaction defines binding motif for type III secretion translocator , 2009, Proceedings of the National Academy of Sciences.
[33] Elizabeth A Komives,et al. Pre-folding IkappaBalpha alters control of NF-kappaB signaling. , 2008, Journal of molecular biology.
[34] D. Heinz,et al. Structure of the Yersinia enterocolitica type III secretion translocator chaperone SycD. , 2007, Journal of molecular biology.
[35] Rodrigo Lopez,et al. Clustal W and Clustal X version 2.0 , 2007, Bioinform..
[36] B. Finlay,et al. Type III Secretion Systems and Disease , 2007, Clinical Microbiology Reviews.
[37] Hans Wolf-Watz,et al. Protein delivery into eukaryotic cells by type III secretion machines , 2006, Nature.
[38] Sophie E Jackson,et al. Local and long-range stability in tandemly arrayed tetratricopeptide repeats. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[39] Patrice Gouet,et al. ESPript: analysis of multiple sequence alignments in PostScript , 1999, Bioinform..
[40] Angray S. Kang,et al. Accessing of recombinant human monoclonal antibodies from patient libraries by eukaryotic ribosome display. , 2012, Human antibodies.